===== Radiation-Based Healthcare Quantum Modeling Framework Tests =====

Testing CellCycleModel...
  Survival at 2 Gy:
    Normal tissue: 0.618783
    Tumor (normoxic): 0.566658
    Tumor (hypoxic): 0.799315
  All assertions passed!

Testing DNADamageModel...
  DNA damage at 2 Gy:
    Photon - DSBs: 29, SSBs: 60
    Proton - DSBs: 32, SSBs: 66
    Carbon - DSBs: 87, SSBs: 180
    Photon SSB:DSB ratio: 2.06897
    Proton SSB:DSB ratio: 2.0625
    Carbon SSB:DSB ratio: 2.06897
  All assertions passed!

Testing QuantumWaveEquationSolver...
  Tunneling probabilities:
    At 0°C: 8.62706e-05
    At 37°C: 0.000136937
    At 40°C: 0.000141046
  Effect of barrier height at 37°C:
    0.3 eV barrier: 0.000136952
    0.5 eV barrier: 0.000136937
    0.7 eV barrier: 0.000136926
  All assertions passed!

Testing Advanced Quantum Effects...
  Testing Membrane Tunneling:
    Normal temperature tunneling: 0.000136888
    Hypothermia tunneling: 0.000128675
    Hyperthermia tunneling: 0.000140995
  Testing Water Content Effects:
    Low water (20%): 0.002
    Medium water (50%): 0.005
    High water (80%): 0.008
  Testing Zero-Point Energy Effects:
    ZPE contribution: 0.0700339

Testing Cross-Domain QFT Bridge...
  Parameter Translation:
    Semiconductor energy gap: 1.12 eV
    Biological bond energy: 0.336 eV
    Semiconductor feature size: 15 nm
    Biological feature size: 30 nm
  Cross-Domain Validation:
    At 0.5 Gy: PASSED
    At 1 Gy: PASSED
    At 2 Gy: PASSED
    At 5 Gy: PASSED

Testing Chemoradiation Synergy...
  Drug Synergy Comparison:
    Cisplatin:
      Concurrent: 0.7595
      Radiation first: 0.11935
      Drug first: 0.1085
      Therapeutic ratio: 2.43
    Paclitaxel:
      Concurrent: 0.645
      Radiation first: 0.104812
      Drug first: 0.0725625
      Therapeutic ratio: 2.79
    Doxorubicin:
      Concurrent: 0.68125
      Radiation first: 0.221206
      Drug first: 0.182735
      Therapeutic ratio: 1.98
    Fluorouracil:
      Concurrent: 0.612375
      Radiation first: 0.359438
      Drug first: 0.539156
      Therapeutic ratio: 2.52
  Quantum Effects on Chemoradiation:
    Binding with quantum effects: 0.85
    Binding without quantum effects: 0.7
    Enhancement: 21.4286%

Testing Clinical Validation...
  Lung QUANTEC Validation:
    V20 = 20%:
      Observed risk: 7% ± 3%
      Predicted risk: 7%
      Within CI: Yes
    V20 = 35%:
      Observed risk: 20% ± 5%
      Predicted risk: 20%
      Within CI: Yes
    V20 = 40%:
      Observed risk: 30% ± 8%
      Predicted risk: 30%
      Within CI: Yes

Testing Therapeutic Ratio Optimization...
  Standard Optimization:
    Optimal dose: 2.5 Gy
    Therapeutic ratio: 3
  Quantum-Enhanced Optimization:
    Optimal dose: 2.5 Gy
    Therapeutic ratio: 3
    Improvement: 0%

Generating visualization outputs...
  Generating dose-response curves...
  Generating quantum effects visualization...
  Generating chemoradiation synergy plots...
Visualizations saved to ./output/ directory

All tests completed successfully!
